Genetics of Bietti Crystalline Dystrophy
- PMID: 27228076
- DOI: 10.1097/APO.0000000000000209
Genetics of Bietti Crystalline Dystrophy
Abstract
Bietti crystalline dystrophy (BCD) is an inherited retinal degenerative disease characterized by crystalline deposits in the retina, followed by progressive atrophy of the retinal pigment epithelium (RPE), choriocapillaris, and photoreceptors. CYP4V2 has been identified as the causative gene for BCD. The CYP4V2 gene belongs to the cytochrome P450 superfamily and encodes for fatty acid ω-hydroxylase of both saturated and unsaturated fatty acids. The CYP4V2 protein is localized most abundantly within the endoplasmic reticulum in the RPE and is postulated to play a role in the physiological lipid recycling system between the RPE and photoreceptors to maintain visual function. Electroretinographic assessments have revealed progressive dysfunction of rod and cone photoreceptors in patients with BCD. Several genotypes have been associated with more severe phenotypes based on clinical and electrophysiological findings. With the advent of multimodal imaging with spectral domain optical coherence tomography, fundus autofluorescence, and adaptive optics scanning laser ophthalmoscopy, more precise delineation of BCD severity and progression is now possible, allowing for the potential future development of targets for gene therapy.
Similar articles
-
Detailed functional and structural phenotype of Bietti crystalline dystrophy associated with mutations in CYP4V2 complicated by choroidal neovascularization.Ophthalmic Genet. 2016 Dec;37(4):445-452. doi: 10.3109/13816810.2015.1126616. Epub 2016 Mar 30. Ophthalmic Genet. 2016. PMID: 27028354 Free PMC article.
-
Evaluation of Photoreceptors in Bietti Crystalline Dystrophy with CYP4V2 Mutations Using Adaptive Optics Scanning Laser Ophthalmoscopy.Am J Ophthalmol. 2016 Jan;161:196-205.e1. doi: 10.1016/j.ajo.2015.10.018. Epub 2015 Oct 30. Am J Ophthalmol. 2016. PMID: 26521715
-
Detailed phenotypic and genotypic characterization of bietti crystalline dystrophy.Ophthalmology. 2014 Jun;121(6):1174-84. doi: 10.1016/j.ophtha.2013.11.042. Epub 2014 Jan 28. Ophthalmology. 2014. PMID: 24480711
-
CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD).Biochem Pharmacol. 2022 Jan;195:114841. doi: 10.1016/j.bcp.2021.114841. Epub 2021 Nov 16. Biochem Pharmacol. 2022. PMID: 34798124 Review.
-
[Progress in the studies of molecular genetics in Bietti crystalline corneoretinal dystrophy].Zhonghua Yan Ke Za Zhi. 2012 Oct;48(10):948-51. Zhonghua Yan Ke Za Zhi. 2012. PMID: 23302251 Review. Chinese.
Cited by
-
A novel mutation of CYP4V2 gene associated with Bietti crystalline dystrophy complicated by choroidal neovascularization.Int J Ophthalmol. 2022 Jun 18;15(6):940-946. doi: 10.18240/ijo.2022.06.11. eCollection 2022. Int J Ophthalmol. 2022. PMID: 35814885 Free PMC article.
-
Structural and functional phenotypic features and molecular analysis of Indian patients with Bietti crystalline dystrophy.Indian J Ophthalmol. 2022 Jul;70(7):2526-2532. doi: 10.4103/ijo.IJO_2146_21. Indian J Ophthalmol. 2022. PMID: 35791149 Free PMC article.
-
Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity.J Xenobiot. 2024 May 1;14(2):575-603. doi: 10.3390/jox14020034. J Xenobiot. 2024. PMID: 38804287 Free PMC article. Review.
-
En face OCT analysis of Bietti's crystalline dystrophy.Am J Ophthalmol Case Rep. 2023 Nov 25;33:101963. doi: 10.1016/j.ajoc.2023.101963. eCollection 2024 Mar. Am J Ophthalmol Case Rep. 2023. PMID: 38162804 Free PMC article.
-
Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications.Int J Mol Sci. 2019 Aug 31;20(17):4274. doi: 10.3390/ijms20174274. Int J Mol Sci. 2019. PMID: 31480463 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical